Biocyte

About Biocyte

Established in 2006 on the French Riviera, Biocyte is a laboratory specializing in nutricosmetics, a market segment that merges nutrition with cosmetics. The company was founded by Philippe Bruneau, who utilized his prior experience in the food supplement industry to pioneer the brand. In 2009, Frédéric Levy, a doctor of pharmacy with a background in the pharmaceutical industry and a specialist in food supplements, joined as a partner and General Manager, bringing further expertise to the company. Their shared vision was to develop a range of supplements focused on anti-aging by working from the inside out.

Biocyte operates in the beauty and wellness industry, specifically targeting the growing nutricosmetics and anti-aging markets. The business develops and manufactures health supplements and personal care products with a portfolio of over 100 products. Its core product lines focus on ingestible supplements that offer an alternative to topical applications like injections of collagen, elastin, or melanin. The company's product categories include solutions for skin, hair, sun care, slimming, and overall health and longevity. Key offerings are based on ingredients such as hyaluronic acid, collagen, keratin, and various vitamins and minerals, available in forms like capsules, powders, gummies, and vials. Biocyte was among the first to introduce oral forms of hyaluronic acid and keratin. The company's revenue model is based on the sale of these products through a multi-channel distribution network that includes pharmacies, personal care stores, and its own e-commerce website.

After years of strong growth and raising over $4.32 million in funding from investors like Sofipaca and Turenne Groupe, Biocyte was acquired by Havea Group on February 1, 2023. This acquisition was part of Havea's strategy to expand its portfolio in the nutricosmetics sector and strengthen its international presence, particularly leveraging Biocyte's significant activity in markets like China. At the time of the acquisition, Biocyte had a reported turnover of €23 million and employed 50 people. The company continues to operate as a brand within the Havea Group, which aims to become a European leader in natural health.